729209254	729209254	CD	B-NP	O
|	|	NNP	I-NP	O
WMC	WMC	NNP	I-NP	O
|	|	VBD	B-VP	O
67063503	67063503	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
6477327	6477327	CD	B-NP	O
|	|	CC	I-NP	O
3/27/2005	3/27/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
CAD	CAD	NN	I-NP	I-protein
|	|	NN	I-NP	I-protein
|	|	NN	I-NP	I-protein
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
6/10/2005	6/10/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
5/24/2005	5/24/2005	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
FILIPPONE	FILIPPONE	NNP	B-NP	O
,	,	,	O	O
WINFORD	WINFORD	NNP	B-NP	O
015-56-74-9	015-56-74-9	CD	I-NP	O
Ce	Ce	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
CAR	CAR	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
PATIENT	PATIENT	NN	I-NP	O
ON	ON	NN	I-NP	O
:	:	:	O	O
6/28/05	6/28/05	CD	B-NP	O
AT	AT	NN	I-NP	O
04	04	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
MALETZ	MALETZ	NN	B-NP	O
,	,	,	O	O
GASTON	GASTON	NNP	B-NP	O
RASHAD	RASHAD	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Rehabilitation	Rehabilitation	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ECASA	ECASA	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ASPIRIN	ASPIRIN	NNP	I-NP	O
ENTERIC	ENTERIC	NNP	I-NP	O
COATED	COATED	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
325	325	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
LASIX	LASIX	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
60	60	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
GEMFIBROZIL	GEMFIBROZIL	NNP	I-NP	O
600	600	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/17/05	10/17/05	CD	B-NP	O
by	by	IN	B-PP	O
KORWIN	KORWIN	NNP	B-NP	O
,	,	,	O	O
DARIUS	DARIUS	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
GEMFIBROZIL	GEMFIBROZIL	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
GEMFIBROZIL	GEMFIBROZIL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
NPH	NPH	NNP	I-NP	O
HUMULIN	HUMULIN	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
NPH	NPH	NNP	I-NP	O
HUMAN	HUMAN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
54	54	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
QAM	QAM	NNP	I-NP	O
;	;	:	O	O
32	32	CD	B-NP	O
UNITS	UNITS	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
SC	SC	NNP	I-NP	O
54	54	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
QAM	QAM	NNP	I-NP	O
32	32	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
REGULAR	REGULAR	NNP	I-NP	O
HUMAN	HUMAN	NNP	I-NP	O
Sliding	Sliding	NNP	I-NP	O
Scale	Scale	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
subcutaneously	subcutaneously	RB	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
SC	SC	NN	I-NP	B-protein
AC+HS	AC+HS	NN	I-NP	I-protein
If	If	IN	B-SBAR	I-protein
BS	BS	NNP	B-NP	I-protein
is	be	VBZ	B-VP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
125	125	CD	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
0	0	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
125-150	125-150	CD	B-NP	O
,	,	,	O	O
then	then	RB	O	O
give	give	VB	B-VP	O
2	2	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
151-200	151-200	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
3	3	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
201-250	201-250	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
4	4	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
251-300	251-300	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
6	6	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
301-350	301-350	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
8	8	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
351-400	351-400	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
10	10	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
and	and	CC	O	O
call	call	VB	B-VP	O
HO	HO	NN	B-NP	B-protein
Call	Call	NN	I-NP	I-protein
HO	HO	NN	I-NP	I-protein
if	if	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
400	400	CD	B-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
10/17/05	10/17/05	CD	B-NP	O
by	by	IN	B-PP	O
HOLTZBERG	HOLTZBERG	NN	B-NP	O
,	,	,	O	O
TONEY	TONEY	NN	B-NP	B-protein
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
KCL	KCL	NNP	B-NP	O
IMMEDIATE	IMMEDIATE	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
PO	PO	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
77917824	77917824	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
to	to	TO	B-VP	O
replete	replete	VB	I-VP	O
k	k	NN	B-NP	O
NIFEREX-150	NIFEREX-150	NN	I-NP	O
150	150	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
please	please	VB	B-VP	O
give	give	VB	B-NP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
separate	separate	JJ	I-NP	O
time	time	NN	I-NP	O
from	from	IN	B-PP	O
levofloxacin	levofloxacin	NN	B-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/17/05	10/17/05	CD	B-NP	O
by	by	IN	B-PP	O
SCHWOYER	SCHWOYER	NNP	B-NP	O
,	,	,	O	O
JAMIE	JAMIE	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	B-NP	O
&	&	CC	I-NP	B-protein
POLYSACCHARIDE	POLYSACCHARIDE	NNP	I-NP	I-protein
IRON	IRON	NNP	I-NP	I-protein
COMPLEX	COMPLEX	NNP	I-NP	I-protein
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
separate	separate	VB	I-VP	O
temporally	temporally	RB	B-ADVP	O
from	from	IN	B-PP	O
levo	levo	NN	B-NP	B-protein
administration	administration	NN	I-NP	I-protein
NITROGLYCERIN	NITROGLYCERIN	NN	I-NP	I-protein
1/150	1/150	CD	I-NP	I-protein
-LRB-	-LRB-	HYPH	I-NP	I-protein
0.4	0.4	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	I-protein
1	1	CD	I-NP	I-protein
TAB	TAB	NN	I-NP	I-protein
SL	SL	NN	I-NP	I-protein
q	q	NN	I-NP	I-protein
5	5	CD	B-NP	I-protein
minutes	minute	NNS	I-NP	I-protein
X	X	SYM	O	I-protein
3	3	CD	B-NP	I-protein
PRN	PRN	NN	I-NP	I-protein
Chest	Chest	NNP	I-NP	I-protein
Pain	Pain	NNP	I-NP	I-protein
HOLD	HOLD	NNP	I-NP	I-protein
IF	IF	NNP	I-NP	I-protein
:	:	:	O	O
SBP	SBP	NN	B-NP	B-DNA
<	<	SYM	O	I-DNA
100	100	CD	B-NP	I-DNA
ZOCOR	ZOCOR	NN	I-NP	I-DNA
-LRB-	-LRB-	NN	I-NP	I-DNA
SIMVASTATIN	SIMVASTATIN	NN	I-NP	I-DNA
-RRB-	-RRB-	NN	I-NP	I-DNA
80	80	CD	I-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
QHS	QHS	NNP	I-NP	I-DNA
Food/Drug	Food/Drug	NNP	I-NP	I-DNA
Interaction	Interaction	NNP	I-NP	I-DNA
Instruction	Instruction	NNP	I-NP	I-DNA
Avoid	Avoid	NNP	I-NP	I-DNA
grapefruit	grapefruit	NN	I-NP	I-DNA
unless	unless	IN	B-SBAR	I-DNA
MD	MD	NN	B-NP	I-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

Override	Override	NNP	B-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
10/17/05	10/17/05	CD	B-NP	O
by	by	IN	B-PP	O
MARISCAL	MARISCAL	NN	B-NP	O
,	,	,	O	O
MARIANO	MARIANO	NN	B-NP	O
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
GEMFIBROZIL	GEMFIBROZIL	NNP	B-NP	O
PO	PO	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
34446815	34446815	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
GEMFIBROZIL	GEMFIBROZIL	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
GEMFIBROZIL	GEMFIBROZIL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
TOPROL	TOPROL	NN	I-NP	O
XL	XL	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
METOPROLOL	METOPROLOL	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
SUST	SUST	NN	I-NP	O
.	.	.	O	O

REL	REL	NN	B-NP	B-protein
.	.	.	O	O
-RRB-	-RRB-	NNP	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O

12.5	12.5	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
1/14	1/14	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

Number	Number	NN	B-NP	O
of	of	IN	B-PP	O
Doses	Dose	NNS	B-NP	O
Required	Require	VBN	B-VP	O
-LRB-	-LRB-	HYPH	B-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
5	5	CD	B-NP	O
IMDUR	IMDUR	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ISOSORBIDE	ISOSORBIDE	NN	I-NP	O
MONONIT	MONONIT	NN	I-NP	O
.	.	.	O	O

-LRB-	-LRB-	NN	B-NP	O
SR	SR	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
90	90	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Give	Give	NNP	I-NP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
empty	empty	JJ	I-NP	O
stomach	stomach	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
give	give	VBP	B-VP	O
1hr	1hr	NN	B-NP	O
before	before	IN	B-SBAR	O
or	or	CC	O	O
2hr	2hr	NN	B-NP	O
after	after	IN	B-PP	O
food	food	NN	B-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
PLAVIX	PLAVIX	NN	I-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
CLOPIDOGREL	CLOPIDOGREL	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	O	I-protein
75	75	CD	B-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	I-protein
ESOMEPRAZOLE	ESOMEPRAZOLE	NNP	I-NP	I-protein
20	20	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	O
DIET	DIET	NNP	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Walking	Walk	VBG	B-VP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
PCP	PCP	NN	B-NP	O
in	in	IN	B-PP	O
1-2	1-2	CD	B-NP	O
weeks	week	NNS	I-NP	O
,	,	,	O	O
Dr	Dr	NNP	B-NP	O
Vanblaricum	Vanblaricum	NNP	I-NP	O
in	in	IN	B-PP	O
1-2	1-2	CD	B-NP	O
weeks	week	NNS	I-NP	O
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
NKA	NKA	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
CAD	CAD	NNP	I-NP	O
OTHER	OTHER	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
CAD	CAD	NNP	I-NP	O
s/p	s/p	NN	I-NP	O
4v	4v	CD	I-NP	O
CABG	CABG	NN	I-NP	B-protein
'94	'94	CD	B-NP	I-protein
-LRB-	-LRB-	HYPH	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
CHF	CHF	NN	I-NP	O
,	,	,	O	O
EF	EF	NN	B-NP	B-protein
50	50	CD	B-NP	I-protein
%	%	NN	I-NP	I-protein
'01	'01	CD	B-NP	I-protein
-LRB-	-LRB-	HYPH	I-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
DM	DM	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitu	VBZ	B-VP	O
-RRB-	-RRB-	NNP	B-NP	O
Anemia	Anemia	NNP	I-NP	O
,	,	,	O	O
32-36	32-36	CD	B-NP	O
-LRB-	-LRB-	HYPH	I-NP	O
anemia	anemia	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
CVA	CVA	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
cerebrovascular	cerebrovascular	JJ	I-NP	O
accident	accident	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
s/p	s/p	NN	I-NP	O
CCY	CCY	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
S/P	S/P	NN	I-NP	O
cholecystectomy	cholecystectomy	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Blindness	Blindness	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
visual	visual	JJ	I-NP	O
impairment	impairment	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
none	none	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
none	none	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
70	70	CD	B-NP	O
yo	yo	NN	I-NP	O
WF	WF	NN	I-NP	O
with	with	IN	B-PP	O
h/o	h/o	NN	B-NP	O
CAD	CAD	NN	I-NP	O
s/p	s/p	NN	I-NP	O
CABG	CABG	NN	I-NP	O
,	,	,	O	O
CHF	CHF	NN	B-NP	B-protein
,	,	,	O	O
CVA	CVA	NN	B-NP	B-protein
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
anemia	anemia	NN	I-NP	O
,	,	,	O	O
adm	adm	NN	B-NP	O
w	w	NN	I-NP	O
CP	CP	NN	I-NP	O
x	x	SYM	B-NP	O
1	1	CD	I-NP	O
day	day	NN	I-NP	O
;	;	:	O	O
awoke	awoke	NN	B-NP	O
at	at	IN	B-PP	O
rehab	rehab	NN	B-NP	O
with	with	IN	B-PP	O
urinary	urinary	JJ	B-NP	O
urgency	urgency	NN	I-NP	O
and	and	CC	I-NP	O
nurse	nurse	NN	I-NP	O
not	not	RB	O	O
available	available	JJ	B-ADJP	O
,	,	,	O	O
had	have	VBD	B-VP	O
cp	cp	NN	B-NP	B-DNA
that	that	WDT	B-NP	O
spont	spont	VBD	B-VP	O
resolved	resolve	VBN	I-VP	O
;	;	:	O	O
No	No	DT	B-NP	O
orthopnea/PND	orthopnea/PND	NN	I-NP	O
,	,	,	O	O
LE	LE	NN	B-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
LH/dizzy	LH/dizzy	NNP	B-NP	O
,	,	,	O	O
chills	chill	NNS	B-NP	O
,	,	,	O	O
EKG	EKG	NN	B-NP	B-protein
showed	show	VBD	B-VP	I-protein
lat	lat	JJ	B-NP	I-protein
ST	ST	NN	I-NP	I-protein
depr	depr	NN	I-NP	I-protein
,	,	,	O	O
NZ	NZ	NN	B-NP	B-protein
-LRB-	-LRB-	SYM	O	I-protein
-	-	HYPH	O	O
-RRB-	-RRB-	SYM	O	O
x1	x1	NN	B-NP	O
;	;	:	O	O
Exam	Exam	NN	B-NP	O
:	:	:	O	O
NAD	NAD	NN	B-NP	O
.	.	.	O	O

JVD	JVD	NN	B-NP	O
<	<	SYM	I-NP	O
10	10	CD	I-NP	O
cm	cm	NN	I-NP	O
.	.	.	O	O

RRR	RRR	NN	B-NP	O
3/6	3/6	CD	I-NP	O
SEM	SEM	NN	I-NP	O
+	+	SYM	B-NP	O
S3	S3	NN	I-NP	B-protein
.	.	.	O	O

CTAB	CTAB	NN	B-NP	B-protein
.	.	.	O	O

Abd	Abd	NN	B-NP	O
dist	dist	NN	I-NP	O
,	,	,	O	O
tympanic	tympanic	NN	B-NP	O
.	.	.	O	O

Guaiac	Guaiac	JJ	B-NP	O
neg	neg	NN	I-NP	O
.	.	.	O	O

no	no	DT	B-NP	O
LE	LE	NN	I-NP	O
edema	edema	NN	I-NP	O
bilat	bilat	NN	I-NP	O
.	.	.	O	O

Hospital	Hospital	NNP	B-NP	O
Course	Course	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

CV	CV	NN	B-NP	O
:	:	:	O	O
I-recent	I-recent	JJ	B-NP	O
cath	cath	NN	I-NP	O
11/8	11/8	CD	I-NP	O
showed	show	VBD	B-VP	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
prox	prox	NN	I-NP	O
LAD	LAD	NN	I-NP	O
,	,	,	O	O
90	90	CD	B-NP	O
%	%	NN	I-NP	O
LCx	LCx	NN	I-NP	O
,	,	,	O	O
40	40	CD	B-NP	O
%	%	NN	I-NP	O
marg	marg	NN	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
100	100	CD	I-NP	O
%	%	NN	I-NP	O
prox	prox	NN	I-NP	O
RCA	RCA	NN	I-NP	O
,	,	,	O	O
2	2	CD	B-NP	O
occl	occl	NN	I-NP	O
+	+	SYM	B-NP	O
1	1	CD	I-NP	O
patent	patent	NN	I-NP	O
CABG	CABG	NN	I-NP	O
v	v	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
unchgd	unchgd	NN	I-NP	O
from	from	IN	B-PP	O
last	last	JJ	B-NP	O
cath	cath	NN	I-NP	O
in	in	IN	B-PP	O
'99	'99	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

pt	pt	NN	B-NP	O
was	be	VBD	B-VP	O
r/o	r/o	NN	B-NP	O
with	with	IN	B-PP	O
nz	nz	NN	B-NP	O
's	's	POS	B-NP	O
ans	an	NNS	I-NP	O
serail	serail	VBP	B-VP	O
EKG	EKG	NNP	B-NP	O
's	's	POS	B-NP	O
;	;	:	O	O
needs	need	VBZ	B-VP	O
to	to	TO	I-VP	O
Cont	Cont	VB	I-VP	O
med	med	JJ	B-NP	O
mgmt	mgmt	NN	I-NP	O
w	w	NN	I-NP	O
ASA	ASA	NN	I-NP	O
,	,	,	O	O
ACE	ACE	NN	B-NP	O
,	,	,	O	O
Plavix	Plavix	NNP	B-NP	O
.	.	.	O	O

P-H/o	P-H/o	NNP	B-NP	O
CHF	CHF	NNP	I-NP	O
w	w	NN	I-NP	O
likely	likely	RB	B-NP	O
diast	diast	NN	I-NP	O
dysfxn	dysfxn	NN	I-NP	O
,	,	,	O	O
echo	echo	NN	B-NP	O
4/2	4/2	CD	I-NP	O
showed	show	VBD	B-VP	O
EF	EF	NN	B-NP	O
55	55	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
WMA	WMA	NN	I-NP	O
,	,	,	O	O
tr	tr	NN	B-NP	B-protein
MR	MR	NN	I-NP	I-protein
,	,	,	O	O
trivial	trivial	JJ	B-NP	O
peric	peric	JJ	I-NP	O
eff	eff	NN	I-NP	O
.	.	.	O	O

pt	pt	NN	B-NP	O
remained	remain	VBD	B-VP	O
euvolumic	euvolumic	JJ	B-ADJP	O
in	in	IN	B-PP	O
house	house	NN	B-NP	O
on	on	IN	B-PP	O
aint	aint	NN	B-NP	O
lasix	lasix	NN	I-NP	O
;	;	:	O	O
R/R	R/R	NN	B-NP	O
:	:	:	O	O
Pt	Pt	NN	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
on	on	IN	B-PP	O
toprol	toprol	NN	B-NP	O
75	75	CD	I-NP	O
on	on	IN	B-PP	O
admit	admit	NN	B-NP	O
but	but	CC	O	O
has	have	VBZ	B-VP	O
HR	HR	NN	B-NP	B-protein
here	here	RB	B-ADVP	O
in	in	IN	B-PP	O
40s	40s	CD	B-NP	O
when	when	WRB	B-ADVP	O
awake	awake	NN	B-NP	O
w/o	w/o	NN	I-NP	O
any	any	DT	B-NP	O
B-Blocker	B-Blocker	NNP	I-NP	O
.	.	.	O	O

will	will	MD	B-VP	O
dc	dc	VB	I-VP	O
on	on	IN	B-PP	O
12.5	12.5	CD	B-NP	O
qd	qd	NN	I-NP	O
;	;	:	O	O
consid	consid	JJ	B-NP	O
er	er	NN	I-NP	O
o/p	o/p	NN	I-NP	O
EP	EP	NN	I-NP	O
eval	eval	NN	I-NP	O
for	for	IN	B-PP	O
pacer	pacer	NN	B-NP	O
to	to	TO	B-VP	O
get	get	VB	I-VP	O
B-blocker	B-blocker	NNP	B-NP	O
on	on	IN	B-PP	O
baord	baord	NN	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Endo	Endo	NNP	B-NP	O
:	:	:	O	O
pt	pt	NN	B-NP	O
was	be	VBD	B-VP	O
cont	cont	JJ	B-ADJP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
nph	nph	NN	B-NP	O
+	+	SYM	B-NP	O
RISS	RISS	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
:	:	:	O	O
Cr	Cr	NNP	B-NP	O
Stable	Stable	NNP	I-NP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
please	please	VB	B-VP	O
take	take	VB	I-VP	O
all	all	DT	B-NP	O
meds	med	NNS	I-NP	O
as	as	IN	B-SBAR	O
prescribed	prescribe	VBN	B-VP	O
;	;	:	O	O
if	if	IN	B-SBAR	O
you	you	PRP	B-NP	O
HR	HR	NN	I-NP	O
is	be	VBZ	B-VP	O
low	low	JJ	B-ADJP	O
<	<	SYM	O	O
45	45	CD	B-NP	O
please	please	NN	I-NP	O
call	call	VB	B-VP	O
your	your	PRP$	B-NP	O
doctor	doctor	NN	I-NP	O
immediately	immediately	RB	B-ADVP	O
;	;	:	O	O
monitor	monitor	NN	B-NP	O
weights	weight	NNS	I-NP	O
;	;	:	O	O
f/u	f/u	NN	B-NP	O
with	with	IN	B-PP	O
pcp	pcp	NN	B-NP	O
and	and	CC	I-NP	O
cardiogist	cardiogist	NN	I-NP	O
in	in	IN	B-PP	O
1-2	1-2	CD	B-NP	O
weeks	week	NNS	I-NP	O
;	;	:	O	O
DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Satisfactory	Satisfactory	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
pt	pt	NN	B-NP	O
to	to	TO	B-VP	O
cont	cont	VB	I-VP	O
on	on	IN	B-PP	O
anti	anti	AFX	B-NP	O
anginal	anginal	JJ	I-NP	O
regimen	regimen	NN	I-NP	O
and	and	CC	I-NP	O
maint	maint	NN	I-NP	O
lasix	lasix	NN	I-NP	O
;	;	:	O	O
moniotr	moniotr	NN	B-NP	O
weights	weight	NNS	I-NP	O
;	;	:	O	O
pt/ot	pt/ot	NN	B-NP	O
bid	bid	NN	I-NP	O
;	;	:	O	O
consider	consider	VB	B-VP	O
o/p	o/p	NN	B-NP	O
eval	eval	NN	I-NP	O
for	for	IN	B-PP	O
possible	possible	JJ	B-NP	O
ppm	ppm	NN	I-NP	O
if	if	IN	B-SBAR	O
bradycardis	bradycardis	NN	B-NP	O
still	still	RB	B-ADVP	O
an	an	DT	B-NP	O
issue	issue	NN	I-NP	O
;	;	:	O	O
abx	abx	NN	B-NP	O
for	for	IN	B-PP	O
7	7	CD	B-NP	O
days	day	NNS	I-NP	O
for	for	IN	B-PP	O
UTI	UTI	NN	B-NP	O
;	;	:	O	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
FUERTE	FUERTE	NNP	B-NP	O
,	,	,	O	O
HORACE	HORACE	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
RZ77	RZ77	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
6/28/05	6/28/05	CD	I-NP	O
@	@	NN	I-NP	O
02	02	CD	I-NP	O
:	:	:	O	O
13	13	CD	B-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

